Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States.
BMC Pulm Med
; 22(1): 18, 2022 Jan 10.
Article
in En
| MEDLINE
| ID: mdl-35000589
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridones
/
Idiopathic Pulmonary Fibrosis
/
Antifibrotic Agents
/
Indoles
Type of study:
Health_economic_evaluation
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
BMC Pulm Med
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: